Shawn Kwatra, MD, discusses the effects of poorly controlled or severe atopic dermatitis on patients’ quality of life and how to measure patient-reported outcomes.
Back
The Significance of Achieving Optimal Treatment Targets in Atopic Dermatitis
Shawn Kwatra, MD, provides clinical insights on how patient-reported incomes can improve quality of life in patients with atopic dermatitis.
The Significance of Achieving Optimal Treatment Targets in Atopic Dermatitis
Episodes
All
All
An expert on atopic dermatitis provides insights on how the evolving treatment landscape has impacted clinician and patient expectations.
Shawn Kwatra, MD, provides an overview of oral JAK inhibitors for the treatment of atopic dermatitis, highlighting data from clinical trials.
An expert on skin conditions provides an overview of TARGET-DERM, a real-world study of patient-reported outcomes in atopic dermatitis.
Shawn Kwatra, MD, discusses the durability of treatments for atopic dermatitis and provides advice for clinicians on improving patients’ quality of life.
Advertisement
Advertisement
Trending on HCPLive
1
VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes
2
Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study
3
After Sickle Cell Gene Therapy, What Comes Next?
4
New Liver Cancer BEACON-HCC Framework Shows 96.6% Concordance in Pilot
5